Загрузка...
Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
The management of patients with moderate to severe inflammatory bowel disease was transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a considerable number of patients do not respond to anti-TNF induction therapy (primary nonresponse) or lose response to treatment...
Сохранить в:
| Опубликовано в: : | Gastroenterol Hepatol (N Y) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Millennium Medical Publishing
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935028/ https://ncbi.nlm.nih.gov/pubmed/31892912 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|